BRIEF published on 10/16/2024 at 07:05, 1 month 5 days ago Appointment of Olivier Falut as Financial Director of EUROAPI Appointment Financial Director EUROAPI Olivier Falut FOCUS-27 Transformation
PRESS RELEASE published on 10/16/2024 at 07:00, 1 month 5 days ago Olivier Falut appointed EUROAPI’s Chief Financial Officer Olivier Falut appointed EUROAPI's Chief Financial Officer. He brings 30 years of financial management experience in the industrial sector. EUROAPI focuses on innovative active ingredient solutions for global health Chief Financial Officer Industrial Sector EUROAPI Active Ingredient Solutions Olivier Falut
BRIEF published on 10/10/2024 at 20:43, 1 month 10 days ago EUROAPI secures financing for its FOCUS-27 plan Funding Sanofi EUROAPI Hybrid Bond FOCUS-27 Plan
PRESS RELEASE published on 10/10/2024 at 20:38, 1 month 10 days ago EUROAPI completes the financing of its FOCUS-27 plan and moves forward with its execution EUROAPI completes financing of FOCUS-27 plan, refinancing €451M Credit Facility & issuing €200M Hybrid Bond, enhancing collaboration with Sanofi Financing Partnership Sanofi EUROAPI FOCUS-27
BRIEF published on 06/18/2024 at 07:05, 5 months 3 days ago EUROAPI and Priothera Enter CDMO Collaboration to Advance Oncology Project CDMO Oncology EUROAPI Priothera Mocravimod
PRESS RELEASE published on 06/18/2024 at 07:00, 5 months 3 days ago EUROAPI and Priothera enter into CDMO collaboration to advance oncology project EUROAPI and Priothera have entered a 5-year CDMO collaboration to advance an innovative oncology molecule for blood cancers, aiming to improve CAR-T cell therapies EUROAPI Priothera Mocravimod CDMO Collaboration Oncology Project
BRIEF published on 06/06/2024 at 17:58, 5 months 14 days ago EUROAPI Accelerates Financing Discussions for FOCUS-27 Project Financing Strategic Transformation EUROAPI FOCUS-27
PRESS RELEASE published on 06/06/2024 at 17:53, 5 months 14 days ago Market update : FOCUS-27 transformation project financing EUROAPI appoints mandataire ad hoc for FOCUS-27 project financing discussions, making substantial progress. Learn more about EUROAPI and its active ingredient solutions Project Financing EUROAPI FOCUS-27 Mandataire Ad Hoc Active Ingredient Solutions
BRIEF published on 06/06/2024 at 07:05, 5 months 15 days ago EUROAPI Reaches Major Health IPCEI Milestone with Official Notification from European Commission Pharmaceutical Industry European Commission EUROAPI IPCEI Public Funding
PRESS RELEASE published on 06/06/2024 at 07:00, 5 months 15 days ago EUROAPI reaches major Health IPCEI milestone with official notification from European Commission EUROAPI selected for EUR 1 billion IPCEI funding by European Commission to enhance pharmaceutical sector competitiveness and sustainability European Commission R&D EUROAPI IPCEI Pharmaceutical Sector
Published on 11/21/2024 at 13:30, 37 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 37 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 7 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 7 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 7 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 32 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 52 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 9 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 47 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 22 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 22 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
